Trump admin rule forces PBMs to disclose secret payments data

A new federal rule will require pharmacy benefit managers to disclose fees and compensation details currently kept private. This marks a regulatory shift in healthcare pricing transparency, potentially affecting drug pricing dynamics and PBM business models. The rule's implementation and industry response remain uncertain.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works